Becton, Dickinson and Co. | BDX - Ativo Circulante





Ativo Circulante Alterar Data
Abbott USD 25.51B 488M 2026-03
Agilent USD 4.76B 148M 2026-03
Align Technology USD 2.66B 7.62M 2026-06
AngioDynamics USD 161.35M 4.69M 2025-09
Baxter International USD 6.99B 142M 2026-06
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Bio-Rad Laboratories USD 3.02B 78.4M 2026-06
Boston Scientific USD 7.97B 712M 2026-06
Cooper Companies USD 2.3B 166M 2026-03
Danaher USD 13.38B 554M 2026-06
Dentsply International USD 1.93B 83M 2026-06
Dexcom USD 4.09B 245.1M 2026-06
Edwards Lifesciences USD 6.82B 590.2M 2026-06
Globus Medical USD 2.22B 17.39M 2026-06
Insulet USD 1.85B 139.6M 2026-06
Integra LifeSciences USD 1.19B 19.46M 2026-06
Intuitive Surgical USD 12.33B 807.5M 2026-06
J&J USD 59.77B 601M 2026-06
Medtronic USD 24.07B 75M 2025-12
Solventum Corp USD 3.74B 158M 2026-06
Stryker USD 14.42B 1.08B 2026-06
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Teleflex USD 1.88B 16.21M 2026-06
Terumo JPY 906.6B 45.57B 2026-06
Thermo Fisher Scientific USD 23.36B 1.05B 2026-06
Zimmer Biomet Holdings USD 5.1B 134.2M 2026-06